MedTrace Logo

Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers

NCT04630574 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-02-20

No results posted yet for this study

Summary

The study proposes to identify deviant speech dimensions in patients with HD at presymptomatic and declared stages of the disease, compared to healthy subjects, using the computerized MonPaGe speech protocol. This tool is based on a multidimensional and quantified assessment of voice and speech, by a set of targeted acoustic and perceptual criteria.

Conditions

  • Huntington Disease

Interventions

OTHER

Speech evaluation with the clinical evaluation of dysarthria

A first speech evaluation with the clinical evaluation of dysarthria during 30 minutes is proposed to exclude very severe dysarthria.

OTHER

complete assessment of the MonPaGe computerized protocol

The application records directly and anonymously stores speech productions made by the patient.

Sponsors & Collaborators

  • Centre National de la Recherche Scientifique, France

    collaborator OTHER

  • University Hospital, Bordeaux

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-23
Primary Completion
2024-02-05
Completion
2024-02-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04630574 on ClinicalTrials.gov